You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Title |
The balance between two isoforms of LEF-1 regulates colon carcinoma growth
|
---|---|
Published in |
BMC Gastroenterology, May 2012
|
DOI | 10.1186/1471-230x-12-53 |
Pubmed ID | |
Authors |
Shu-Hong Wang, Ke-Jun Nan, Yao-Chun Wang, Wen-Juan Wang, Tao Tian |
Abstract |
Colon cancer is one of the most aggressive human malignancies, with a very poor prognosis. Although it has been suggested that different isoforms of the lymphoid enhancer factor (LEF-1) have opposing biological activities, the biological outcome of aberrant LEF-1 activation in colon cancer is still unclear. The aim of this study was to evaluate the effect of the different LEF-1 phenotypes on the growth of colon carcinoma cell lines. A deeper understanding of these processes might improve the targeted therapies for colon cancer by regulating the expression of LEF-1. |
Mendeley readers
The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 1 | 4% |
Unknown | 27 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 7 | 25% |
Student > Ph. D. Student | 4 | 14% |
Student > Master | 4 | 14% |
Researcher | 2 | 7% |
Student > Doctoral Student | 1 | 4% |
Other | 4 | 14% |
Unknown | 6 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 8 | 29% |
Biochemistry, Genetics and Molecular Biology | 7 | 25% |
Agricultural and Biological Sciences | 5 | 18% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 4% |
Unspecified | 1 | 4% |
Other | 0 | 0% |
Unknown | 6 | 21% |